- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT00231179
The MOM Program: 5 Year Follow-up Study of a Home Visiting Program at The Children's Hospital of Philadelphia (MOM Program)
26. oktober 2015 oppdatert av: Children's Hospital of Philadelphia
The MOM Program Continuation - 5 Year Follow-up
The purpose of the MOM Program Continuation is to promote child development by helping families become more competent in accessing and using available health, developmental and educational resources.
The program focuses are childhood immunizations, Early Intervention services, lead screening, Early Head Start and Head Start enrollment.
The Intervention consists of frequent phone calls and home visits to encourage mothers to have their babies immunized on schedule and to participate in needed developmental and educational services.
The program seeks to fill the gap between children's need for services and mothers' ability to assure their children's participation in those services.
Studieoversikt
Status
Fullført
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
The MOM Program Continuation builds on the work of The MOM Program, a 3 year randomized intervention.
The premise of the MOM Program was that professional support through home visits and frequent phone contacts would improve children's cognitive and behavioral development, ultimately improving their early educational success.
The children were enrolled in the MOM Program at birth.
The MOM Program Continuation provides continued intervention for the children and mothers of the original cohort to assure that the children are prepared for kindergarten entry at 5 years of age and to evaluate the children's cognitive and behavioral outcomes at age 5 years.
The program will also create a longitudinal database to study the linkages between maternal cognitive ability and child cognitive, educational, and behavioral outcomes through entry into school.
Studietype
Intervensjonell
Registrering (Faktiske)
302
Fase
- Fase 3
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiesteder
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, Forente stater, 19104
- The Children's Hospital of Philadelphia
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
4 år til 5 år (Barn)
Tar imot friske frivillige
Nei
Kjønn som er kvalifisert for studier
Alle
Beskrivelse
Inclusion Criteria: Previous enrollment in The MOM Program; child age of 5 years (plus or minus 3 months); willingness to come to office for follow-up assessment visit; parental consent and child assent.
Exclusion Criteria: None.
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Forebygging
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
---|---|
Eksperimentell: Home visiting Intervention
Home visiting intervention group.
|
Home visits and telephone calls keyed to well child visits.
|
Placebo komparator: Control
Control condition did not receive any services.
|
The control group received an information booklet on child/family services upon enrollment and transportation for the follow-up evaluations.
They were called every 4 months to maintain contact information
Andre navn:
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Wechsler Preschool and Primary Scale of Intelligence, Third Edition (WPPSI-III)
Tidsramme: 5 years of age (plus or minus 1 month)
|
Cognitive ability was assessed through the Wechsler Preschool and Primary Scale of Intelligence, Third Edition (WPPSI-III).
The WPPSI-III has been developed and standardized for children ages 2 years, 6 months through 7 years, 3 months of age.
The WPPSI-III yields a Verbal Score, a Performance Score, a General Language Score, and a Full Scale Score.
These scores have a mean of 100 and a standard deviation of 15.
The range of possible values is 50 (worst value) to 150 (best value).
|
5 years of age (plus or minus 1 month)
|
Child Behavior Checklist Internalizing Scale at 5 Years of Age, Percentage of Participants
Tidsramme: at child age of 5 years (plus or minus 1 month)
|
Caregivers completed The Child Behavior Checklist (CBCL) Preschool form from The Achenbach System of Empirically Based Assessment (ASEBA).
The CBCL is standardized for children ages 1.5 to 5 years and measures child internalizing and externalizing behaviors and total problems.
Respondents are asked to rate 99 problem items as 0 for "not true of the child," 1 for "somewhat or sometimes true of the child," and 2 for "very true or often true of the child" based on the past two months.
The range of possible values is 0-100.
Percentage of Participants with Abnormal Behavior is calculated by: % abnormal = # of Abnormal / (# of Normal + # of abnormal).
|
at child age of 5 years (plus or minus 1 month)
|
Child Behavior Checklist Externalizing Scale, Percentage of Abnormality in Participants
Tidsramme: at child age of 5 years (plus or minus 1 month)
|
Caregivers completed The Child Behavior Checklist (CBCL) Preschool form from The Achenbach System of Empirically Based Assessment (ASEBA).
The CBCL is standardized for children ages 1.5 to 5 years and measures child internalizing and externalizing behaviors and total problems.
Respondents are asked to rate 99 problem items as 0 for "not true of the child," 1 for "somewhat or sometimes true of the child," and 2 for "very true or often true of the child" based on the past two months.
The range of possible values is 0-100.
Percentage of Participants with Abnormal Behavior is calculated by: % abnormal = # of Abnormal / (# of Normal + # of abnormal).
|
at child age of 5 years (plus or minus 1 month)
|
Child Behavior Checklist Aggressive Subscale, Percentage of Abnormality in Participants
Tidsramme: at child age of 5 years (plus or minus 1 month)
|
Caregivers completed The Child Behavior Checklist (CBCL) Preschool form from The Achenbach System of Empirically Based Assessment (ASEBA).
The CBCL is standardized for children ages 1.5 to 5 years and measures child internalizing and externalizing behaviors and total problems.
Respondents are asked to rate 99 problem items as 0 for "not true of the child," 1 for "somewhat or sometimes true of the child," and 2 for "very true or often true of the child" based on the past two months.
The range of possible values is 0-100.
Percentage of Participants with Abnormal Behavior is calculated by: % abnormal = # of Abnormal / (# of Normal + # of abnormal).
|
at child age of 5 years (plus or minus 1 month)
|
Child Behavior Checklist Attention Subscale, Percentage of Abnormality in Participants
Tidsramme: child age 5 years (plus or minus 1 month)
|
Caregivers completed The Child Behavior Checklist (CBCL) Preschool form from The Achenbach System of Empirically Based Assessment (ASEBA).
The CBCL is standardized for children ages 1.5 to 5 years and measures child internalizing and externalizing behaviors and total problems.
Respondents are asked to rate 99 problem items as 0 for "not true of the child," 1 for "somewhat or sometimes true of the child," and 2 for "very true or often true of the child" based on the past two months.
The range of possible values is 0-100.
Percentage of Participants with Abnormal Behavior is calculated by: % abnormal = # of Abnormal / (# of Normal + # of abnormal).
|
child age 5 years (plus or minus 1 month)
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart
1. februar 2004
Primær fullføring (Faktiske)
1. februar 2007
Studiet fullført (Faktiske)
1. februar 2007
Datoer for studieregistrering
Først innsendt
30. september 2005
Først innsendt som oppfylte QC-kriteriene
30. september 2005
Først lagt ut (Anslag)
4. oktober 2005
Oppdateringer av studieposter
Sist oppdatering lagt ut (Anslag)
23. november 2015
Siste oppdatering sendt inn som oppfylte QC-kriteriene
26. oktober 2015
Sist bekreftet
1. oktober 2015
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Andre studie-ID-numre
- 2003-10-3495
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
produkt produsert i og eksportert fra USA
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Barneutvikling
-
PepsiCo Global R&DFullførtKollagensyntese | Rate of Force (RFD) DevelopmentForente stater
-
MedDay Pharmaceuticals SAEurofins OptimedAvsluttetFriske Frivillige | Nedsatt leverfunksjon av moderat Child Pugh-kategoriFrankrike, Ungarn
-
RenJi HospitalFullførtBlodplateantall/miltdiameterforhold | Child-Pugh-klassifiseringKina
-
National Institute of Allergy and Infectious Diseases...Clinical Trials in Organ Transplantation; Cooperative Clinical Trials in...FullførtNyretransplantasjon | Nyretransplantasjonsmottaker | Graftfunksjon/overlevelse | de Novo HLA Antibodies DevelopmentForente stater
-
Stanford UniversityNational Cancer Institute (NCI)AvsluttetTilbakevendende hepatocellulært karsinom | Child-Pugh klasse A | Child-Pugh klasse BForente stater, Japan
-
Jay ZuckermanFullførtUtviklingskoordinasjonsforstyrrelse | Utviklingsdyspraksi | Clumsy Child SyndromeIsrael
-
Ohio State University Comprehensive Cancer CenterVarian Medical SystemsFullførtChild-Pugh klasse A | Stadium IIIA Hepatocellulært karsinom | Stadium IIIB Hepatocellulært karsinom | Stage IIIC hepatocellulært karsinom | Stage IVA Hepatocellulært karsinom | Stadium IVB hepatocellulært karsinom | Child-Pugh klasse BForente stater
-
Centre Hospitalier Universitaire DijonFullførtChild-Pugh A Hepatocellulært karsinomFrankrike
-
Centre Hospitalier Universitaire DijonFullførtIkke-opererbart ikke-metastatisk hepatocellulært karsinom | Child A/B7 CirrhoseFrankrike
-
Roswell Park Cancer InstituteMerck Sharp & Dohme LLCAktiv, ikke rekrutterendeAvansert hepatocellulært karsinom hos voksne | Child-Pugh klasse A | Stadium III hepatocellulært karsinom | Stadium IIIA Hepatocellulært karsinom | Stadium IIIB Hepatocellulært karsinom | Stage IIIC hepatocellulært karsinom | Stadium IV hepatocellulært karsinom | Stage IVA Hepatocellulært karsinom | Stadium...Forente stater
Kliniske studier på Home visiting professional support model
-
University of New MexicoPatient-Centered Outcomes Research InstituteFullført